Arrowstreet Capital
MURA

Arrowstreet Capital’s Mural Oncology MURA Stock Holding History

Arrowstreet Capital’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-61,156
Closed -$299K – 1690
2024
Q1 		$299K Buy
61,156
+9,597
+19% +$46.6K ﹤0.01% 1527
2023
Q4 		$305K Buy
+51,559
New +$207K ﹤0.01% 1291

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital's MURA Position: Q2 2024 in Review

Arrowstreet Capital sold out of Mural Oncology (MURA) in Q2 2024, closing a stake of 61,156 shares — an estimated $299K sold.

Arrowstreet Capital first reported a position in MURA in Q4 2023 and held it in 2 quarters. The position peaked at $305K in Q4 2023. 86 funds tracked by Wall St. Rank hold MURA as of Q2 2024.

  • Arrowstreet Capital reported no remaining Mural Oncology position as of Q2 2024 after selling out during the quarter.
  • Arrowstreet Capital sold 61,156 Mural Oncology shares in Q2 2024, an estimated $299K.
  • Arrowstreet Capital first reported a position in Mural Oncology in Q4 2023 and held it in 2 quarters.
  • Arrowstreet Capital's Mural Oncology position peaked at $305K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.